A new law dubbed “Right to Try” lets terminally ill patients request experimental drugs without getting FDA approval. But the agency’s chief says he will continue to operate a program to approve such requests, and new regulations may be needed.
from WSJ.com: US Business https://ift.tt/2JaBho8
via IFTTT
No comments:
Post a Comment